Searched for
SEVERIN SCHWAN
Roche buys US rights to Roivant bowel disease drug in $7.1 billion dealRoche has announced its acquisition of Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial $7.1 billio...- Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...
- Credit Suisse's vice-chairman Severin Schwan to step down in board reorganisationCredit Suisse's vice-chairman is stepping down, barely weeks after some shareholders threatened to vote against his re-election to the boar...
- European shares edge higher on boost from oil stocksLondon's FTSE 100 led gains among its continental peers, rising 0.4%.
- Trials and Hopes: Way ahead for Covid-19 treatmentThe leaders of big pharma came together for a joint press conference to give an update on the way ahead for Covid-19 treatment and vaccines...
- Roche India head Lara Bezerra set to exitA Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the d...
- India is so big, we can’t ignore it, we always keep it on our radar: Severin Schwan, Roche CEOSchwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...
- Swiss voters reject strictest executive pay limitsSwiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees on Sunday.
- Long-serving Roche chairman Franz Humer to step down next yearHumer was the driving force behind Roche's acquisition of U.S. biotech company Genentech and has been the chairman for more than a decade.
- Roche Holding AG makes $5.7 bn offer for Illumina IncA takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.
- Roche says half-year profit down 29 per centPharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.
Load More
